Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Lymphoblastic Leukemia Hematologic Diseases Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Leukemia Leukemia, Lymphoid Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Precursor Cell Lymphoblastic Leukemia-Lymphoma

Age range

5 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sohag university Hospital

Sohag, Egypt

Location contact

Magdy M Amin, professor

CONTACT

About this study

Role of neutrophil to lymph ratio , lymphocyte to monocyte ratio and platelet to lymphocyte in acute lymphoblastic leukemia adults and pediatric patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients newly diagnosed ALL

Exclusion criteria

others malignanices
ALL on therapy

Treatment and study plan

Complete blood count

Diagnostic Test

measure cbc and blood ratios to compare their values with respone of patients to treatment

Primary outcomes

neutrophil to lymphocyte ratio

Time frame: 1 year

count of neutophils comparing lymphocytees

Study contacts

Contact information is provided by the study sponsor or research team.

heba a Ahmed, assistant professor

CONTACT

omnia A Mohammed, resident

CONTACT

[email protected]

01121809920

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Dec 24, 2024
Registry last updated: Dec 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting